The iShares Russell 2000 ETF (NYSEMKT:IWM) provides broad exposure to small-capitalization U.S. equities, whereas the State Street SPDR S&P 500 ETF Trust (NYSEMKT:SPY) tracks the performance of the largest companies in the domestic market. Investors often use IWM and SPY to balance market-cap exposure in their portfolios. While SPY serves as the primary benchmark for U.S. large-cap performance, IW...
The iShares Russell 2000 ETF (NYSEMKT:IWM) provides broad exposure to small-capitalization U.S. equities, whereas the State Street SPDR S&P 500 ETF Trust (NYSEMKT:SPY) tracks the performance of the largest companies in the domestic market. Investors often use IWM and SPY to balance market-cap exposure in their portfolios. While SPY serves as the primary benchmark for U.S. large-cap performance, IWM targets small-cap companies that may offer different growth trajectories and economic sensitivities. This match-up examines how these two domestic heavyweights compare on risk, return, and internal composition. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield. Continue reading
hapabapa/iStock Editorial via Getty Images On April 29th , AbbVie ( ABBV ) reported impressive earnings that beat Wall Street estimates as Q1 2026 revenues reached $15 billion (+12.4% YoY). The firm's immunology blockbuster Skyrizi powered headline numbers, reaching $4.48 billion in Q1 sales (+30.9% YoY), enabling management to raise 2026 EPS guidance to a mid-point of $14.18. Despite these robust...
hapabapa/iStock Editorial via Getty Images On April 29th , AbbVie ( ABBV ) reported impressive earnings that beat Wall Street estimates as Q1 2026 revenues reached $15 billion (+12.4% YoY). The firm's immunology blockbuster Skyrizi powered headline numbers, reaching $4.48 billion in Q1 sales (+30.9% YoY), enabling management to raise 2026 EPS guidance to a mid-point of $14.18. Despite these robust results, the anxiety among Wall Street analysts was palpable on the earnings call . For example, JPMorgan's Christ Schott spoke to developments in the immunology and inflammation landscape, specifically the recent approval of the oral competitor Icotyde, stating: "The Street is increasingly concerned about what this means relative to your portfolio." Other analysts questioned management's long-term view that Skyrizi has peak sales upside relative to the 2031 $33 billion sell-side forecast. In my view, it is a common trap for investors to aggressively discount explosive growth at scale. For example, last year critics claimed that Nvidia ( NVDA ) was "too big to grow," while in 2012 pundits thought Apple's ( AAPL ) iPhone sales would soon hit a ceiling due to "the law of large numbers." Frequently investors presented with 'blue sky' upside choose to aggressively discount it, coming up with myriad reasons why growth must hit a ceiling long before it actually does. The skepticism surrounding AbbVie's Skyrizi appears unfounded for three primary reasons: The efficacy gap remains wide: The primary source of anxiety is the roll-out of new oral therapies, specifically the JNJ/Protagonist drug Icotyde. This bear thesis posits that the convenience of an oral pill will erode Skyrizi's market share. However, Skyrizi remains the undisputed best-in-class biologic. CCO Jeff Stewart noted on the call that efficacy comparisons are "quite a bit lower." The Expanding Market: Skeptics assume that the immunology market is a 'zero-sum game.' Stewart also pointed out that oral drugs like Otezla a...
Watch: Fetterman Blasts Democrats For Running On 'F*ck Trump'; Calls Socialism Moronic Authored by Steve Watson via Modernity.news, Pennsylvania Democrat Sen. John Fetterman has reiterated that he is done with the insanity gripping his party. In a series of raw appearances on Bill Maher’s show and a new Washington Post op-ed, Fetterman is torching the reflexive anti-Trump obsession, the normalizat...
Watch: Fetterman Blasts Democrats For Running On 'F*ck Trump'; Calls Socialism Moronic Authored by Steve Watson via Modernity.news, Pennsylvania Democrat Sen. John Fetterman has reiterated that he is done with the insanity gripping his party. In a series of raw appearances on Bill Maher’s show and a new Washington Post op-ed, Fetterman is torching the reflexive anti-Trump obsession, the normalization of radical left ideas once dismissed as smears, and the sloppy 24-hour news cycle that turns opinions into “news.” Fetterman made clear he refuses to play along with the extremes. “My colleagues and people that are running, whether for the Senate where the House, they are literally running on f*ck Trump,” he said. “I mean, that’s literally—they have campaign commercials with that. It’s absurd,” he noted, adding “And we are getting to that point and I refuse to engage in that extreme, those terms. And we have to find a better way forward.” Sen. John Fetterman (D-PA): “My colleagues and people that are running, whether for the Senate where the House, they are literally running on f*ck Trump.” “I mean, that's literally—they have campaign commercials with that. It's absurd.” “And we are getting to that point and I… pic.twitter.com/A0MselRgIS — RedWave Press (@RedWavePress) May 9, 2026 Fetterman repeated the sentiments in an op-ed in The Washington Post, titled “I Haven’t Changed. Here’s What Has,” writing “My party cannot simply be the opposite of whatever President Donald Trump says.” He stresses, “Working across the aisle is the only way forward” and calls “pointless pile-ons and attacks” unproductive. Fetterman highlights once-mainstream Democratic positions on border security, support for Israel, and avoiding government shutdowns that have now become “toxic” to the party’s fringe base. He declares, “Someone who comes here illegally and commits a violent crime should be deported. Full stop.” "It doesn’t matter if my colleague is in my party or across the aisle," Sen. @Jo...
Bulgac/iStock Unreleased via Getty Images Intel ( INTC ) has gone from $18 to $125 in fourteen months. That's a 590% move on a company that posted negative GAAP earnings last quarter, is burning $2.4 billion per quarter in its foundry segment, and whose consensus analyst target sits 42% below the current price. The stock has an open area gap at $84.59 as part of the post-earnings surge on April 28...
Bulgac/iStock Unreleased via Getty Images Intel ( INTC ) has gone from $18 to $125 in fourteen months. That's a 590% move on a company that posted negative GAAP earnings last quarter, is burning $2.4 billion per quarter in its foundry segment, and whose consensus analyst target sits 42% below the current price. The stock has an open area gap at $84.59 as part of the post-earnings surge on April 28, and my backtests on INTC show a 92% fill rate on up area gaps with a median fill time of four days. I'm buying puts. The Gap INTC gapped up from roughly $67 to $82 on April 24 after reporting Q1 earnings that crushed estimates: $0.29 EPS versus $0.01 consensus and a revenue of $13.58 billion versus estimates of $12.42 billion. The stock has continued to rip higher after this breakaway gap, hitting $125 today (May 9). But the move up was not without an area gap. Now, that gap sits at $84.59. My backtest on INTC up area gaps (white-white pattern, 2009-2026) shows 112 fills out of 122 total gaps, a 92% fill rate. The median fill time is four trading days. For clarification's sake, let me make a distinction between the two gaps. The earnings gap from $67 to $82 is a breakaway gap, driven by a fundamental re-rating of the company. Breakaway gaps don't fill reliably because they reflect a genuine shift in what the market thinks the stock is worth. In contrast, the area gap at $84.59, formed during the momentum-driven run that followed, is the product of enthusiasm, not re-pricing. It's a temporary overreaction that fills. The seasonal data adds to my conviction. INTC in early May has a bearish seasonal tendency: down in 10 of the last 17 years during this window, with a seasonal expected value of -0.36%. It's not an overwhelming number, but it is aligned with the gap-fill direction, which is something I like to see before opening a short trade on an area gap. The Valuation We rarely want to trade a gap when the fundamentals of the stock point in the other direction. Fortunately...
Bulgac/iStock Unreleased via Getty Images Intel ( INTC ) has gone from $18 to $125 in fourteen months. That's a 590% move on a company that posted negative GAAP earnings last quarter, is burning $2.4 billion per quarter in its foundry segment, and whose consensus analyst target sits 42% below the current price. The stock has an open area gap at $84.59 as part of the post-earnings surge on April 28...
Bulgac/iStock Unreleased via Getty Images Intel ( INTC ) has gone from $18 to $125 in fourteen months. That's a 590% move on a company that posted negative GAAP earnings last quarter, is burning $2.4 billion per quarter in its foundry segment, and whose consensus analyst target sits 42% below the current price. The stock has an open area gap at $84.59 as part of the post-earnings surge on April 28, and my backtests on INTC show a 92% fill rate on up area gaps with a median fill time of four days. I'm buying puts. The Gap INTC gapped up from roughly $67 to $82 on April 24 after reporting Q1 earnings that crushed estimates: $0.29 EPS versus $0.01 consensus and a revenue of $13.58 billion versus estimates of $12.42 billion. The stock has continued to rip higher after this breakaway gap, hitting $125 today (May 9). But the move up was not without an area gap. Now, that gap sits at $84.59. My backtest on INTC up area gaps (white-white pattern, 2009-2026) shows 112 fills out of 122 total gaps, a 92% fill rate. The median fill time is four trading days. For clarification's sake, let me make a distinction between the two gaps. The earnings gap from $67 to $82 is a breakaway gap, driven by a fundamental re-rating of the company. Breakaway gaps don't fill reliably because they reflect a genuine shift in what the market thinks the stock is worth. In contrast, the area gap at $84.59, formed during the momentum-driven run that followed, is the product of enthusiasm, not re-pricing. It's a temporary overreaction that fills. The seasonal data adds to my conviction. INTC in early May has a bearish seasonal tendency: down in 10 of the last 17 years during this window, with a seasonal expected value of -0.36%. It's not an overwhelming number, but it is aligned with the gap-fill direction, which is something I like to see before opening a short trade on an area gap. The Valuation We rarely want to trade a gap when the fundamentals of the stock point in the other direction. Fortunately...
(RTTNews) - The Canadian stock market is likely to open with a negative bias on Monday, weighed down by Middle East concerns due to failed peace talks.
(RTTNews) - The Canadian stock market is likely to open with a negative bias on Monday, weighed down by Middle East concerns due to failed peace talks.
FabrikaCr/iStock via Getty Images Introduction So far this year we have seen record highs in the gold price, record highs in the copper price, and record Q1 earnings for Hudbay Minerals ( HBM ). Despite this, the share price has remained flat since my previous article in January. My main argument then was that Hudbay would continue to capitalize on its existing long-life, low-cost assets spread ac...
FabrikaCr/iStock via Getty Images Introduction So far this year we have seen record highs in the gold price, record highs in the copper price, and record Q1 earnings for Hudbay Minerals ( HBM ). Despite this, the share price has remained flat since my previous article in January. My main argument then was that Hudbay would continue to capitalize on its existing long-life, low-cost assets spread across Canada and Peru while progressing its development projects in the USA, a tier-one mining jurisdiction. Since then, they have doubled down on the U.S., announcing the acquisition of Arizona Sonoran in a ~$1.5 billion all-stock deal. This is a large deal for a ~$10 billion market cap company, resulting in significant dilution, but it creates one of the largest North American copper districts and supplements existing assets in the region. The question is whether it is an accretive deal to Hudbay? In this article, we'll dig into Hudbay Minerals' recent results, cover the Arizona Sonoran acquisition, and explain why I believe the shares appear to remain good value. Let's dive in. Q1 Earnings In their latest earnings , Hudbay reported production of 27,900 kt of copper (-10% y/y) and 61,700 ounces of gold (-16% y/y). While the Pampacancha ore deposit in Peru was depleted in December 2025, this was more than offset by the Constancia deposit, whose tonnes mined in Peru actually rose 24% to 10.8 million tonnes with stable grades (Cu: 0.29%, Au: 0.03 g/t, Ag: 3.11 g/t). Although there were falls in copper and silver recovery rates, and actual ore milled only rose slightly (+0.6%), copper production came in at 20,573 tonnes (+1.4% y/y), gold at 8,770 oz (+11% y/y), and silver at 531,199 oz (-4.2% y/y). The Snow Lake gold mine in Manitoba had a much weaker quarter compared to Q1 '25, with gold production falling 20.9% to 47,743 oz. This was reported as being due to lower equipment utilization and labor availability issues, resulting in a decrease in ore mined. Lower gold grades at ...
Rithm Capital ( RITM ) announced on Monday that it had planned to offer $500M aggregate principal amount of senior unsecured notes due 2031. The company plans to use the net proceeds for general corporate purposes, including the repayment of certain debt. Shares +0.51%. More on Rithm Capital Don't Chase mREIT Yield: Rithm Outshines AGNC Investment AGNC Vs. Rithm: Pure-Play Agency Safety Beats The ...
Rithm Capital ( RITM ) announced on Monday that it had planned to offer $500M aggregate principal amount of senior unsecured notes due 2031. The company plans to use the net proceeds for general corporate purposes, including the repayment of certain debt. Shares +0.51%. More on Rithm Capital Don't Chase mREIT Yield: Rithm Outshines AGNC Investment AGNC Vs. Rithm: Pure-Play Agency Safety Beats The Hybrid Black Box Rithm Capital: Diversification In Progress - Rich Dividends Trigger Buy Rating Rithm projects $6.5B-$7B 2026 production at Genesis while targeting $150M-$175M EBITDA Rithm Capital stock edges up on strong Q1 segment revenues
Bayer Leverkusen and Eintracht Frankfurt among teams facing a nervy last day with their managers precariously placed Not the end, perhaps, but certainly the denouement. After the penultimate weekend of the Bundesliga season some big issues remain open; the confirmation of the fourth team to qualify for the Champions League, who will be the two teams to drop to the second tier and which side will g...
Bayer Leverkusen and Eintracht Frankfurt among teams facing a nervy last day with their managers precariously placed Not the end, perhaps, but certainly the denouement. After the penultimate weekend of the Bundesliga season some big issues remain open; the confirmation of the fourth team to qualify for the Champions League, who will be the two teams to drop to the second tier and which side will get a two-legged opportunity to reprieve themselves. Yet the German game is nothing if not reliably businesslike in getting some of next season’s key parameters set before the current exercise is done. There was no need for official announcements here, though, with the results doing the explaining for us. Or, in a few cases, the performances. There has been considerable doubt, for example, whether Kasper Hjulmand would continue as Bayer Leverkusen coach next season. Now, there is none. Continue reading...
Greenlane Renewables ( GRN:CA ) said on Monday that it has signed definitive agreements with Panasonic do Brasil Limitada to establish local production of its landfill gas upgrading technology in Brazil. Under the agreement, Panasonic will manufacture Greenlane’s Cascade LF and Cascade MS product lines at its facilities in São José dos Campos, São Paulo state, under a technology license granted by...
Greenlane Renewables ( GRN:CA ) said on Monday that it has signed definitive agreements with Panasonic do Brasil Limitada to establish local production of its landfill gas upgrading technology in Brazil. Under the agreement, Panasonic will manufacture Greenlane’s Cascade LF and Cascade MS product lines at its facilities in São José dos Campos, São Paulo state, under a technology license granted by Greenlane. Panasonic will invest 8 million to 10 million reais ($2 million to $3 million Canadian) in facility modifications, tooling, and production equipment, while Greenlane will retain responsibility for product design, supply chain management, sales, commissioning, and servicing. The companies aim to ship the first system by the end of 2026. Greenlane said Cascade LF is its next-generation landfill gas upgrading technology designed to improve methane recovery while lowering costs, while Cascade MS is its membrane separation biogas upgrading solution for large biodigester projects. The company said Brazil represents a significant growth market for biomethane, with production capacity projected to increase up to sevenfold by 2035. Initial production capacity is expected to support about 12 units annually of 2,500 Nm3/hour systems, or six units annually of 5,000 Nm3/hour systems, based on a single production shift. Source: Press Release More on Greenlane Renewables Inc. Greenlane Renewables Inc. (GRN:CA) Q4 2025 Earnings Call Transcript Historical earnings data for Greenlane Renewables Inc. Financial information for Greenlane Renewables Inc.
New Wave Offshore Energy已获壳牌选定,为其位于巴西盐下桑托斯盆地的Orca项目提供海洋担保检验服务。 该合同涵盖该海上开发项目的海洋担保与保障服务。据估计,该项目含有约3.7亿桶可采资源量。 New Wave Offshore的工作范围包括船舶检验、工程审查,以及跨多个项目阶段的运输与安装作业监督。 该公司表示,相关工作将涉及独立审查与验证,以确保在海上执行期间达成约定的项...
New Wave Offshore Energy已获壳牌选定,为其位于巴西盐下桑托斯盆地的Orca项目提供海洋担保检验服务。 该合同涵盖该海上开发项目的海洋担保与保障服务。据估计,该项目含有约3.7亿桶可采资源量。 New Wave Offshore的工作范围包括船舶检验、工程审查,以及跨多个项目阶段的运输与安装作业监督。 该公司表示,相关工作将涉及独立审查与验证,以确保在海上执行期间达成约定的项目担保要求。 公司创始人兼首席执行官Kyle Eddings表示:“这项合同明确验证了我们的技术深度和运营纪律。被壳牌选中提供海洋担保服务,证实了业界对我们诚信、注重细节地执行海上项目能力的信心。” “我们始终秉持的核心理念是:一个由诚实敬业、技术过硬的专家组成的团队能够为客户带来无与伦比的价值。看到这一理念得到如此级别的认可,我们感到非常自豪。” 该合同进一步拓展了New Wave Offshore在海上能源项目领域的海洋担保检验业务组合,涵盖浮式生产储卸装置安装、海底施工及退役等活动。 责任编辑:张俊 SF065
Apple (NASDAQ: AAPL) and Microsoft (NASDAQ: MSFT) reported earnings less than 24 hours apart in late April. Apple delivered a record March quarter powered by the iPhone 17 cycle. Microsoft posted an AI annual revenue run rate of $37 billion, up 123%. Both beat. Only one is monetizing generative AI at scale today. iPhone 17 ... Got $25,000? Apple vs Microsoft- Only One Tech Titan is Winning The AI ...
Apple (NASDAQ: AAPL) and Microsoft (NASDAQ: MSFT) reported earnings less than 24 hours apart in late April. Apple delivered a record March quarter powered by the iPhone 17 cycle. Microsoft posted an AI annual revenue run rate of $37 billion, up 123%. Both beat. Only one is monetizing generative AI at scale today. iPhone 17 ... Got $25,000? Apple vs Microsoft- Only One Tech Titan is Winning The AI Race
Fugro已获得SSE授予的一份重要岩土工程勘测合同,用于苏格兰北部北海海域的Berwick Bank B海上风电开发项目。 Berwick Bank B是总规模4.1吉瓦的Berwick Bank海上风电项目的一部分,该项目分三个阶段开发,若全面建成,有望成为全球最大的海上风电场。 这家荷兰地理数据专业公司表示,该合同涵盖全面的岩土工程勘察活动,以支持计划在Berwick Bank B场址(占该...
Fugro已获得SSE授予的一份重要岩土工程勘测合同,用于苏格兰北部北海海域的Berwick Bank B海上风电开发项目。 Berwick Bank B是总规模4.1吉瓦的Berwick Bank海上风电项目的一部分,该项目分三个阶段开发,若全面建成,有望成为全球最大的海上风电场。 这家荷兰地理数据专业公司表示,该合同涵盖全面的岩土工程勘察活动,以支持计划在Berwick Bank B场址(占该项目总规划容量的1.4吉瓦)建设的固定式基础风机的基础设计。 勘测工作包括在海床以下钻探深达50米的钻孔,以获取用于风机基础设计的土壤和岩石样本。 Fugro表示,此次勘察将使用其岩土工程船Fugro Quest号和Fugro Zenith号,采用适合该场址复杂海床条件的专业取芯和常规取样技术。 Berwick Bank B项目已于今年早些时候在英国第四轮分配中获得了长期差价合约。 SSE Renewables Berwick Bank项目岩土工程包经理Gordon Rae表示:“启动岩土工程勘察活动为Berwick Bank B风机基础的最终设计提供依据,这是一个重要的里程碑,也展示了SSE对严谨、去风险化项目交付的承诺。” “随着项目向最终投资决策推进,我们很高兴能继续与Fugro的长期合作关系,并期待在Berwick Bank B成功实施一个安全、高效的地质勘察计划。” 责任编辑:张俊 SF065